Back

COR-1167, a new long-acting CRF2 receptor agonist, decreases congestion by improving cardiorenal function in a sheep model of worsening heart failure (WHF)

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - pharmacotherapy 1 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Philip Janiak

Corteria Pharmaceuticals, Paris (France)

7 More presentations in this session

Presentation thumbnail
Influence of ejection fraction on outcomes with sacubitril/valsartan in patients with worsening heart failure with EF>40%: the PARAGLIDE-HF Trial
Doctor A. Peters (Durham, US)
Abstract Slides Video
Presentation thumbnail
The impact of intrarenal venous doppler-guided diuretic management on hospital stay
Doctor M. Passos (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Mild-to-moderate chronic kidney disease predicts underutilisation of guideline-directed medical therapies in patients with acute heart failure
Associate Professor M. Polovina (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Response to up-titration of therapies in patients with new-onset heart failure with and without atrial fibrillation
Ms A. Zandijk (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Heart failure early post discharge appointment: a 2.5-year single-center experience
Doctor M. Passos (Amadora, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure - pharmacotherapy 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Urocortin-2 as a novel biomarker of clinical deterioration in HFpEF: a prospective cohort study
thumbnail
Congress Presentation
Pathophysiological and therapeutic implications of urocortin-2 in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Long-acting CRF2 receptor agonist COR-1389 improves cardiopulmonary function parameters in monocrotaline-induced pulmonary hypertension and right heart failure rat model

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources